133 research outputs found
Efficiency of quantum controlled non-Markovian thermalization
We study optimal control strategies to optimize the relaxation rate towards
the fixed point of a quantum system in the presence of a non-Markovian
dissipative bath. Contrary to naive expectations that suggest that memory
effects might be exploited to improve optimal control effectiveness,
non-Markovian effects influence the optimal strategy in a non trivial way: we
present a necessary condition to be satisfied so that the effectiveness of
optimal control is enhanced by non-Markovianity subject to suitable unitary
controls. For illustration, we specialize our findings for the case of the
dynamics of single qubit amplitude damping channels. The optimal control
strategy presented here can be used to implement optimal cooling processes in
quantum technologies and may have implications in quantum thermodynamics when
assessing the efficiency of thermal micro-machines.Comment: 7 pages, 3 figure
Speeding up and slowing down the relaxation of a qubit by optimal control
We consider a two-level quantum system prepared in an arbitrary initial state
and relaxing to a steady state due to the action of a Markovian dissipative
channel. We study how optimal control can be used for speeding up or slowing
down the relaxation towards the fixed point of the dynamics. We analytically
derive the optimal relaxation times for different quantum channels in the ideal
ansatz of unconstrained quantum control (a magnetic field of infinite
strength). We also analyze the situation in which the control Hamiltonian is
bounded by a finite threshold. As byproducts of our analysis we find that: (i)
if the qubit is initially in a thermal state hotter than the environmental
bath, quantum control cannot speed up its natural cooling rate; (ii) if the
qubit is initially in a thermal state colder than the bath, it can reach the
fixed point of the dynamics in finite time if a strong control field is
applied; (iii) in the presence of unconstrained quantum control it is possible
to keep the evolved state indefinitely and arbitrarily close to special initial
states which are far away from the fixed points of the dynamics.Comment: 11 pages, 6 figure
The Spitzer c2d Survey of Nearby Dense Cores: VI. The Protostars of Lynds Dark Nebula 1221
Observations of Lynds Dark Nebula 1221 from the Spitzer Space Telescope are
presented. These data show three candidate protostars towards L1221, only two
of which were previously known. The infrared observations also show signatures
of outflowing material, an interpretation which is also supported by radio
observations with the Very Large Array. In addition, molecular line maps from
the Five College Radio Astronomy Observatory are shown.
One-dimensional dust continuum modelling of two of these protostars, IRS1 and
IRS3, is described. These models show two distinctly different protostars
forming in very similar environments. IRS1 shows a higher luminosity and larger
inner radius of the envelope than IRS3. The disparity could be caused by a
difference in age or mass, orientation of outflow cavities, or the impact of a
binary in the IRS1 core.Comment: accepted for publication in Ap
The Australian Imaging, Biomarkers and Lifestyle (AIBL) Study of Aging: Methodology and Baseline Characteristics of 1112 Individuals Recruited for a Longitudinal Study of Alzheimer\u27s Disease
Background: The Australian Imaging, Biomarkers and Lifestyle (AIBL) flagship study of aging aimed to recruit 1000 individuals aged over 60 to assist with prospective research into Alzheimer\u27s disease (AD). This paper describes the recruitment of the cohort and gives information about the study methodology, baseline demography, diagnoses, medical comorbidities, medication use, and cognitive function of the participants. Methods: Volunteers underwent a screening interview, had comprehensive cognitive testing, gave 80 ml of blood, and completed health and lifestyle questionnaires. One quarter of the sample also underwent amyloid PET brain imaging with Pittsburgh compound B (PiB PET) and MRI brain imaging, and a subgroup of 10% had ActiGraph activity monitoring and body composition scanning. Results: A total of 1166 volunteers were recruited, 54 of whom were excluded from further study due to comorbid disorders which could affect cognition or because of withdrawal of consent. Participants with AD (211) had neuropsychological profiles which were consistent with AD, and were more impaired than participants with mild cognitive impairment (133) or healthy controls (768), who performed within expected norms for age on neuropsychological testing. PiB PET scans were performed on 287 participants, 100 had DEXA scans and 91 participated in ActiGraph monitoring. Conclusion: The participants comprising the AIBL cohort represent a group of highly motivated and well-characterized individuals who represent a unique resource for the study of AD. They will be reassessed at 18-month intervals in order to determine the predictive utility of various biomarkers, cognitive parameters and lifestyle factors as indicators of AD, and as predictors of future cognitive decline
Sex differences on multikinase inhibitors toxicity in patients with advanced gastroenteropancreatic neuroendocrine tumours
Purpose: There is an increasing interest in the role of sex and gender in cancer pa-tients. The impact of sex differences in oncological systemic therapies is still unknown, and there is a lack of evidence specially in uncommon neoplasms like neuroendocrine tumours (NET). In the present study, we combine the differential toxicities by sex in five published clinical trials with multikinase inhibitors (MKI) in gastroenteropancreatic (GEP) NET.Methods: We performed a pooled univariate analysis of reported toxicity in patients treated in five phase 2 and phase 3 clinical trials with MKI in the GEP NET setting: sunitinib (SU11248, SUN1111), Pazopanib (PAZONET), sorafenib-bevacizumab (GETNE0801) and Lenvatinib (TALENT). Differential toxicities between male and female patients were evaluated considering relationship with study drug and different weights of each trial by random effect adjustment.Results: We found nine toxicities which were more frequent in female patients (leukopenia, alopecia, vomiting, headache, bleeding, nausea, dysgeusia, neutrophil count decreased and dry mouth) and two toxicities being more frequent in male patients (Anal Symptoms and Insomnia). Asthenia and diarrhoea were the only severe (Grade 3-4) toxicities more frequent in female pa-tients.Conclusions: Sex-related differences in toxicity with the MKI treatment require targeted in-formation and individualised management of patients with NET. Differential reporting of toxicity should be promoted when clinical trials are published.(c) 2023 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY -NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
Very-high energy gamma-ray astronomy: A 23-year success story in high-energy astroparticle physics
Very-high energy (VHE) gamma quanta contribute only a minuscule fraction -
below one per million - to the flux of cosmic rays. Nevertheless, being neutral
particles they are currently the best "messengers" of processes from the
relativistic/ultra-relativistic Universe because they can be extrapolated back
to their origin. The window of VHE gamma rays was opened only in 1989 by the
Whipple collaboration, reporting the observation of TeV gamma rays from the
Crab nebula. After a slow start, this new field of research is now rapidly
expanding with the discovery of more than 150 VHE gamma-ray emitting sources.
Progress is intimately related with the steady improvement of detectors and
rapidly increasing computing power. We give an overview of the early attempts
before and around 1989 and the progress after the pioneering work of the
Whipple collaboration. The main focus of this article is on the development of
experimental techniques for Earth-bound gamma-ray detectors; consequently, more
emphasis is given to those experiments that made an initial breakthrough rather
than to the successors which often had and have a similar (sometimes even
higher) scientific output as the pioneering experiments. The considered energy
threshold is about 30 GeV. At lower energies, observations can presently only
be performed with balloon or satellite-borne detectors. Irrespective of the
stormy experimental progress, the success story could not have been called a
success story without a broad scientific output. Therefore we conclude this
article with a summary of the scientific rationales and main results achieved
over the last two decades.Comment: 45 pages, 38 figures, review prepared for EPJ-H special issue "Cosmic
rays, gamma rays and neutrinos: A survey of 100 years of research
Macrophage-Specific ApoE Gene Repair Reduces Diet-Induced Hyperlipidemia and Atherosclerosis in Hypomorphic Apoe Mice
Apolipoprotein (apo) E is best known for its ability to lower plasma cholesterol and protect against atherosclerosis. Although the liver is the major source of plasma apoE, extra-hepatic sources of apoE, including from macrophages, account for up to 10% of plasma apoE levels. This study examined the contribution of macrophage-derived apoE expression levels in diet-induced hyperlipidemia and atherosclerosis.Hypomorphic apoE (Apoe(h/h)) mice expressing wildtype mouse apoE at ∼2-5% of physiological levels in all tissues were derived by gene targeting in embryonic stem cells. Cre-mediated gene repair of the Apoe(h/h) allele in Apoe(h/h)LysM-Cre mice raised apoE expression levels by 26 fold in freshly isolated peritoneal macrophages, restoring it to 37% of levels seen in wildtype mice. Chow-fed Apoe(h/h)LysM-Cre and Apoe(h/h) mice displayed similar plasma apoE and cholesterol levels (55.53±2.90 mg/dl versus 62.70±2.77 mg/dl, n = 12). When fed a high-cholesterol diet (HCD) for 16 weeks, Apoe(h/h)LysM-Cre mice displayed a 3-fold increase in plasma apoE and a concomitant 32% decrease in plasma cholesterol when compared to Apoe(h/h) mice (602.20±22.30 mg/dl versus 888.80±24.99 mg/dl, n = 7). On HCD, Apoe(h/h)LysM-Cre mice showed increased apoE immunoreactivity in lesional macrophages and liver-associated Kupffer cells but not hepatocytes. In addition, Apoe(h/h)LysM-Cre mice developed 35% less atherosclerotic lesions in the aortic root than Apoe(h/h) mice (167×10(3)±16×10(3) µm(2) versus 259×10(3)±56×10(3) µm(2), n = 7). This difference in atherosclerosis lesions size was proportional to the observed reduction in plasma cholesterol.Macrophage-derived apoE raises plasma apoE levels in response to diet-induced hyperlipidemia and by such reduces atherosclerosis proportionally to the extent to which it lowers plasma cholesterol levels
Hippocampal–anterior thalamic pathways for memory: uncovering a network of direct and indirect actions
This review charts recent advances from a variety of disciplines that create a new perspective on why the multiple hippocampal–anterior thalamic interconnections are together vital for human episodic memory and rodent event memory. Evidence has emerged for the existence of a series of parallel temporal–diencephalic pathways that function in a reciprocal manner, both directly and indirectly, between the hippocampal formation and the anterior thalamic nuclei. These extended pathways also involve the mammillary bodies, the retrosplenial cortex and parts of the prefrontal cortex. Recent neuropsychological findings reveal the disproportionate importance of these hippocampal–anterior thalamic systems for recollective rather than familiarity-based recognition, while anatomical studies highlight the precise manner in which information streams are kept separate but can also converge at key points within these pathways. These latter findings are developed further by electrophysiological stimulation studies showing how the properties of the direct hippocampal–anterior thalamic projections are often opposed by the indirect hippocampal projections via the mammillary bodies to the thalamus. Just as these hippocampal–anterior thalamic interactions reflect an interdependent system, so it is also the case that pathology in one of the component sites within this system can induce dysfunctional changes to distal sites both directly and indirectly across the system. Such distal effects challenge more traditional views of neuropathology as they reveal how extensive covert pathology might accompany localised overt pathology, and so impair memory
An upper limit to the photon fraction in cosmic rays above 10^19 eV from the Pierre Auger Observatory
An upper limit of 16% (at 95% c.l.) is derived for the photon fraction in cosmic rays with energies above 10^19 eV, based on observations of the depth of shower maximum performed with the hybrid detector of the Pierre Auger Observatory. This is the first such limit on photons obtained by observing the fluorescence light profile of air showers. This upper limit confirms and improves on previous results from the Haverah Park and AGASA surface arrays. Additional data recorded with the Auger surface detectors for a subset of the event sample, support the conclusion that a photon origin of the observed events is not favoured
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1.
In 2008, we published the first set of guidelines for standardizing research in autophagy. Since then, this topic has received increasing attention, and many scientists have entered the field. Our knowledge base and relevant new technologies have also been expanding. Thus, it is important to formulate on a regular basis updated guidelines for monitoring autophagy in different organisms. Despite numerous reviews, there continues to be confusion regarding acceptable methods to evaluate autophagy, especially in multicellular eukaryotes. Here, we present a set of guidelines for investigators to select and interpret methods to examine autophagy and related processes, and for reviewers to provide realistic and reasonable critiques of reports that are focused on these processes. These guidelines are not meant to be a dogmatic set of rules, because the appropriateness of any assay largely depends on the question being asked and the system being used. Moreover, no individual assay is perfect for every situation, calling for the use of multiple techniques to properly monitor autophagy in each experimental setting. Finally, several core components of the autophagy machinery have been implicated in distinct autophagic processes (canonical and noncanonical autophagy), implying that genetic approaches to block autophagy should rely on targeting two or more autophagy-related genes that ideally participate in distinct steps of the pathway. Along similar lines, because multiple proteins involved in autophagy also regulate other cellular pathways including apoptosis, not all of them can be used as a specific marker for bona fide autophagic responses. Here, we critically discuss current methods of assessing autophagy and the information they can, or cannot, provide. Our ultimate goal is to encourage intellectual and technical innovation in the field
- …